| HOME >> BIOLOGY >> TECHNOLOGY |
NEW YORK, Nov. 26, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announced today that Michael Hershman has joined the IntelliCell Board of Directors.
IntelliCell's Chairman and CEO, Dr. Steven Victor, stated, "Our Company is very pleased to announce today that Michael Hershman is joining our Board of Directors. His international experience and accomplishments will add a very significant capability to our Board and our Company. Mr. Hershman has long been recognized as one of the most influential business people worldwide and we are looking forward to working with him as we strengthen the IntelliCell executive management team with world class people."
Said Mr. Hershman, "I am delighted to join the Board of IntelliCell and assist this cutting edge medical technology company which holds the potential to improve the well being of millions of people globally. I look forward to working with Dr. Victor and other Board members to develop IntelliCell as a leading company in Regenerative Medicine and contribute my efforts to creating an outstanding organization."
About IntelliCell BioSciences
IntelliCell BioSciences is a Regenerative Medicine company developing novel technologies that address the regenerative, curative, and preventative conditions of disease states with high unmet clinical needs. The Company has several patent pending applications including an industry unique method of obtaining autologous stromal vascular fraction cells (SVF) from the vasculature surrounding adipose tissue containing adult stem cells and a robust population of regenerative healing cells. The Company is also pioneering the development of autologous and allogeneic cells from living and non-living tissue donors for research purposes. IntelliCell is planning a series of in-human clinical studies with top tier universities for the treatment of osteoarthritis, multiple sclerosis, lower limb i
'/>"/>
| SOURCE IntelliCell BioSciences, Inc. Copyright©2012 PR Newswire. All rights reserved |